First-of-Its-Kind Healthcare-Based Series Premiers on Abu Dhabi’s Big Screens During Abu Dhabi Global Healthcare Week
Strap: H for Hope, the region’s first-ever healthcare series based on real-life patient stories, has been produced by Burjeel Medical City.
Abu Dhabi [14.05.2024]: Emotions ran high at Cinemacity, Al Qana, as Burjeel Medical City (“BMC”) premiered the region’s first-ever healthcare series. Aptly titled H for Hope, the first season features five inspiring and stirring short films. The films are based on patient cases from BMC and include the real doctors who played key roles in these life-transforming stories.
Held as part of Abu Dhabi Global Healthcare Week, the screening showcased the robust healthcare capabilities of Abu Dhabi. It was attended by government officials, dignitaries, healthcare experts, and patients, underscoring the community-wide support for and recognition of the region’s medical achievements. The red carpet was a sight to behold as real patients who had overcome adversity walked alongside the medical professionals who had guided them on their journey.
‘A Deeply Moving Experience’
One of the standout short films of the evening featured the heart-wrenching yet inspiring journey of a couple whose unborn child was diagnosed with spina bifida. Their story took a hopeful turn after a successful in-utero surgery at BMC, guided by the skilled hands of Dr. Mandeep Singh. Several months later, the couple welcomed their healthy baby into the world, a testament to the remarkable medical intervention that took place at the hospital. News of this groundbreaking surgery had gone viral last year.
Another compelling film follows the journey of a young football enthusiast whose life was disrupted by severe pain. He was diagnosed with sickle cell disease at BMC, where under the expert guidance of Dr. Zainul Aabideen, the boy underwent a life-saving bone marrow transplant. His triumphant return to the football field left the audience moved and inspired.
Abu Dhabi’s Capabilities in Focus
H for Hope, a first-of-its-kind healthcare series in the region, blends the personal experiences of patients and their families with the professional skill and care provided by BMC’s world-class clinicians. The series aims to inspire audiences and strengthen Abu Dhabi’s reputation as a center for complex care and medical innovation.
Mr. John Sunil, CEO of Burjeel Holdings, expressed his pride in the series. “Our goal was to use a universal language to showcase Abu Dhabi’s capabilities and share our stories of medical success with a broader audience. These films present narratives of hope and resilience that resonate worldwide, while emphasizing Burjeel’s theme of ‘Safeguarding Your Health at the World’s Safest City’.”
In its inaugural edition, H for Hope is much more than a showcase of BMC’s medical prowess. These short films are reminders of the profound impact medical professionals can have on their patients’ lives, offering a vision of hope and healing for the future.
The video series is available on Burjeel Medical City’s YouTube channel.
(ENDS)
‘There Must be a Comprehensive Regional Strategy to Combat Rare Diseases,’ says Sheikh Nahyan bin Mubarak
‘Our wise leadership is strengthening preventive health care and cooperation with all countries in this field,’ said the Minister while opening the MENA Congress for Rare Diseases.
Abu Dhabi, Thursday 16 May 2024: In the presence and under the patronage of H.E. Sheikh Nahyan bin Mubarak Al Nahyan, Cabinet Member and Minister of Tolerance and Coexistence, the MENA Congress for Rare Diseaseshas commenced in Abu Dhabi. The four-day event brings together 141 speakers, including 51 international experts, from 27 countries. The MENA Congress for Rare Diseases is held in partnership with Burjeel Medical City (BMC), which is the flagship facility of Burjeel Holdings. The largest event in the field, the congress comprises 41 sessions covering a wide range of topics including recent research, advancements in diagnostics and therapeutics, regional experiences, and challenges related to rare diseases.
Sheikh Nahyan, in his inaugural address, emphasized the UAE’s strong commitment to public health and advancing medical knowledge. “Under the leadership of His Highness the President, Sheikh Mohammed bin Zayed Al Nahyan, we, in the UAE, are committed to preventing disease, as well as treating it and caring for patients with empathy and compassion. Our approach is comprehensive: we want to promote preventive care against the conditions that cause disease. At the same time, we are always searching for effective ways to diagnose, treat and manage disease, whether common or rare.”
Sheikh Nahyan focused on the need for partnerships across sectors and regional and international cooperation to combat rare diseases. Speaking to the delegates, he said, “I also share in your conviction that we need an effective regional strategy where combating rare diseases is a national and regional health priority. Such a strategy must be focused and comprehensive: superior medical personnel and first-rate health facilities are essential components. We must also increase public knowledge about these diseases and make people aware of the common risk factors. We must assist patients in learning how to live with a rare disease. Physicians are on the front line of the fight against rare diseases and must embrace patient education as a key part of their role.”
“I am delighted that BMC, with the guidance of Dr. Shamsheer Vayalil, is demonstrating its leadership in our country’s medical sector by hosting this congress. The launch of their project NADER here today also signals their determination to be the best in the field of treating rare diseases,” added Sheikh Nahyan. He also acknowledged the Department of Health – Abu Dhabi’s support in expanding healthcare capabilities and backing impactful initiatives.
Professor Ayman El-Hattab, the congress chairman, and Professor Khaled Musallam, Group Chief Research Officer of Burjeel Holdings and the congress’ scientific committee head, briefed the Minister on the congress agenda.
“In the UAE and under the leadership of His Highness Sheikh Mohamed Bin Zayed Al Nahyan, we have become more aware of the optimal strategy to handle rare disorders, and collaborative research to develop new and curative therapies. BMC further strengthens this commitment through our Center for Research on Rare Blood Disorders (CR-RBD), which has made considerable contributions to improving our understanding of rare hematologic conditions and developing new treatment options through global clinical trials. These efforts, designed to improve the outcomes of patients with rare blood disorders, perfectly align with the goals of this congress,” said Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings.
Engaging Participation
Rare diseases affect at least 5% of the population, and the MENA (Middle East and North African) region has a higher prevalence of rare diseases. The congress agenda was crafted to be comprehensive and inclusive of the majority of rare disorders and focuses on highlighting key unmet needs and potential solutions through best clinical practices and research. More than 1,100 attendees are present at the congress, representing 38 countries, including physicians, students, researchers, representatives of laboratories, pharmaceutical companies and healthcare institutions, along with patients and their families. The congress which began on Thursday will end on Sunday.
[ENDS]
Burjeel Holdings Launches Advanced Day Surgery Center in Al Ain’s Al Dhahir
The Center was inaugurated by His Highness Sheikh Nahyan bin Zayed Al Nahyan in the presence Her Excellency Dr. Noura Khamis Al Ghaithi and other dignitaries
Al Ain, 18 May 2024: As part of its efforts to provide world-class patient care and enhance holistic community wellness, Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has launched an advanced Day Surgery Center at the Al Dhahir area in Al Ain. The state-of-the-art Center, the first of its kind in the Al Dhahir area, was inaugurated by His Highness Sheikh Nahyan bin Zayed Al Nahyan, Chairman of the Board of Trustees of the Zayed Charitable and Humanitarian Foundation.
The ceremony was attended by His Excellency Humaid Al Neyadi, Director of the Office of the Chairman of the Presidential Court; Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH; Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings; John Sunil, CEO of Burjeel Holdings; Dr. Ghuwaya Al-Neyadi, Non-Executive Director of Burjeel Holdings, along with senior government officials and representatives of the prominent families from the area.
The Day Surgery Center, equipped with advanced diagnostic and treatment technologies, ensures patients receive the highest standard of care. It aims to reduce the need for long hospital stays, offering efficient and effective surgical interventions for various medical conditions. Spearheaded by a team of board-certified doctors, the Center is poised to enhance the overall patient experience and well-being through community-led healthcare initiatives. By reducing the need for long-distance commuting for surgical procedures, it enhances healthcare accessibility for the communities in Al Dhahir, Um Ghafah, Mezyad, and surrounding areas.
“We are delighted to attend the opening of the Burjeel Day Surgery Center in Al Dhahir. This Center, catering to all segments of society and offering integrated services that focus on both preventive and curative aspects, is a significant addition to the community. All partners have collaborated closely to establish this facility which will provide day surgery services along with consultations in various specialties. We wish continued success to the Center,” said Dr. Al Ghaithi.
Specializing in a variety of medical fields, including Orthopedics, Gastroenterology, ENT, Urology, Dermatology, Ophthalmology, General Surgery, Pain Management, Gynecology, Plastic Surgery, Pediatrics, Family and Internal Medicine, and Dental Surgery, the Center is designed to provide a rapid and comprehensive treatment experience. With a special focus on community health, it has a robust physiotherapy and rehabilitation department as well.
“The launch of the Day Surgery Center in Al Dhahir aligns with our commitment to expanding our care network to the broader Al Ain community. This advanced facility is designed to deliver top-tier, accessible, and efficient healthcare, ensuring residents receive exceptional care close to home. From prevention to rehabilitation and wellness, our goal is to meet the holistic healthcare needs of the local community. Moreover, we are dedicated to empowering local talents by providing opportunities, while enhancing their expertise with the support of our integrated network,” said John Sunil.
The new center will complement Burjeel Holdings’ three existing medical facilities in Al Ain, providing integrated care with seamless coordination. Complex cases will be efficiently transferred to Burjeel Royal Hospital and Burjeel Royal Asharej for specialized treatment.
“The new facility represents a significant advancement in outpatient surgical care in Al Ain. Our team includes skilled surgeons, experienced anesthetists, and dedicated nursing staff, all committed to delivering top-notch medical care. We are dedicated to ensuring that every member of the local community receives personalized attention and the best possible outcomes,” said Dr. Yasser Sedawy, Medical Director and Specialist in Internal Medicine.
[ENDS]
The Department of Health – Abu Dhabi accredits Burjeel Holdings’ facilities as specialised centres in Orthopaedic Care
Abu Dhabi, UAE, 17 May 2024: On the sidelines of Abu Dhabi Global Healthcare Week, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, announced that Burjeel Hospital Abu Dhabi, Burjeel Medical City and Paley Middle East Clinic are accredited as specialised centres in Orthopaedic Care in the Emirate.
In the presence of HE Mansoor Ibrahim Al Mansouri, Chairman of the Department of Health – Abu Dhabi, HE Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings and John Sunil, CEO of Burjeel Holdings, the accreditation agreement was signed by Dr. Rashed Obaid AlSuwaidi, Executive Director of Healthcare Workforce Planning at the Department of Health - Abu Dhabi and Aysha Almahri, Deputy CEO of Burjeel Medical City.
Dr. Rashed Obaid Alsuwaidi, the Executive Director of Healthcare Workforce Planning at the Department of Health - Abu Dhabi said: “The Department of Health – Abu Dhabi remains committed to empowering healthcare facilities in the emirate with a world-class healthcare ecosystem to improve health and patient outcomes. We firmly believe in the necessity of collaborative efforts between the public and private sectors, particularly in the provision of specialised healthcare services to community members to continuously enhance the quality and accessibility of services for patients in need.”
John Sunil, Group CEO of Burjeel Holdings said: “We are honoured to be accredited as specialized centre in Orthopaedic Care by the Department of Health – Abu Dhabi. This recognition highlights our diverse team of specialists, advanced facilities, and extensive clinical and research capabilities. Our facilities have been instrumental in advancing orthopedic services, reinforcing the Abu Dhabi’s reputation as a leading destination for specialized care. With our team of world-class experts, we are dedicated to elevating comprehensive orthopedic services in the region.”
At Burjeel, orthopaedic experts perform a wide range of complex surgeries, including vertebral tethering surgery for the spine, 3D hologram-assisted knee replacement surgery, joint replacement surgery, and various other orthopedic procedures.
Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, Abu Dhabi Global Healthcare Week is a major government initiative took place between 13 May and 15 May 2024. The event seeks to accelerate collaboration, innovation, and investment, and bring together researchers, policymakers, healthcare specialists, investors, and entrepreneurs across the global healthcare and life-science ecosystem. The always-on platform witnessed a true gathering of pioneering minds and a powerful network of 5,000 attendees, 1,000 delegates, 200 speakers, and 100 exhibitors.
For more information please visit: https://www.adghw.com/
-ENDS-
About Department of Health – Abu Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system.
For further information on DOH, visit https://www.doh.gov.ae/ and follow X, Instagram, Facebook, LinkedIn and YouTube.
For media inquiries, please contact:
Sara Farrah
+971 505030586
Mariam Al Marzooqi,
+971 50 536 6660
About Burjeel Holdings
Founded in 2007, Burjeel Holdings is one of the leading private providers of world-class healthcare services in the UAE and Oman, and it operates a growing specialized healthcare segment in Saudi Arabia. With a network of 82 assets, including 17 hospitals and 42 medical centers, as well as 15 pharmacies and other allied services, the Group collectively provides a premier offering in the Gulf region. Burjeel Holdings’ brands include Burjeel, Medeor, LLH, Lifecare, PhysioTherabia and Tajmeel. It has 13 JCI-accredited facilities, with a total of 1,708 patient beds across its operations in the UAE and Oman and holds a leading position in the UAE. For further information on DOH, visit www.burjeelholdings.com
Burjeel Holdings to Feature Complex Care Capabilities at Abu Dhabi Global Healthcare Week
Under the theme ‘Safeguarding Your Health at the World’s Safest City,’ the Group will showcase its expertise and significant contributions to Abu Dhabi’s healthcare landscape.
Abu Dhabi: Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, is set to feature its innovative solutions and complex care capabilities at the upcoming Abu Dhabi Global Healthcare Week. At the event, the Group will highlight its advanced offerings and patient-centered care through its flagship facility, Burjeel Medical City (“BMC”). This showcase, in line with the theme ‘Safeguarding Your Health at the World’s Safest City’, highlights the Group’s commitment to reinforcing Abu Dhabi’s reputation as a prime destination for medical tourism. The event is scheduled to take place from May 13-15 at the Abu Dhabi National Exhibition Centre (ADNEC).
Key Specialties in Focus
The BMC pavilion, at booth number B030, will spotlight significant advancements from its oncology department, underscoring its integrated approach to cancer care, which includes the latest in precision medicine and targeted therapies and ensuring comprehensive treatment plans tailored to individual patient needs. Key complex care specialties including Bone Marrow Transplantation, Hematology, Advanced Orthopedics, Fetal Medicine and Pediatric subspecialties will also be featured.
The exhibition comes on the heels of groundbreaking strides in the Group’s multi-organ transplant program. Recently, Dr. Rehan Saif, Director of the Burjeel Abdominal Multi-Organ Transplant Program, and his team successfully completed BMC’s first liver transplant. This achievement, along with the center’s established kidney transplant capabilities, demonstrates a major leap forward in the Group’s medical expertise and underscores its commitment to pioneering cutting-edge treatments. The pavilion will also highlight BMC’s soon-to-be-launched Advanced Neuroscience Institute that will specialize in cutting-edge treatments for neurological disorders and will be led by the renowned Dr. Souhel Najjar.
First-of-its-kind Healthcare Series
During Abu Dhabi Global Healthcare Week, Burjeel Holdings will also shine the spotlight on BMC’s comprehensive capabilities by premiering the H for Hope series. A first-of-its-kind healthcare series in the region, it features inspiring stories of patient journeys, illustrating the profound impact of Burjeel’s healthcare services on their lives and well-being.
“We are pleased to be part of this significant event and look forward to contributing to and learning from the global dialogue on healthcare advancement. Our participation is a demonstration of our dedication to elevating healthcare standards regionally and globally, driving forward the vision of making Abu Dhabi a hub for medical excellence and innovation,” said Mr. John Sunil, CEO of Burjeel Holdings.
Abu Dhabi Global Healthcare Week will also serve as a platform to engage with Burjeel Holdings’ leading medical experts and participate in discussions that span a broad array of topics, from industry advancements to cutting-edge research and treatment strategies. Throughout the event, the Group is expected to enter into collaborations with key partners to enhance patient experiences and push the boundaries of technological advancements, research, and innovation.
(ENDS)
Technology Innovation Institute, Burjeel Medical City Partner to Advance Immunotherapy Solutions for Cancer Patients
Synergy promises to redefine oncology therapy and drive personalized treatment for cancer patients
Abu Dhabi-UAE: 15, 05, 2024 – In line with the UAE’s ongoing efforts to revolutionize cancer care, the Technology Innovation Institute (TII), a leading global scientific research center and the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), today announced that it has joined forces with Burjeel Medical City (BMC), the flagship quaternary care hospital under Burjeel Holdings, to pioneer novel immunotherapy solutions for cancer treatment. The collaboration is focused on engineering T-cell based therapeutics, including Chimeric Antigen Receptor T (CAR-T) cell therapy and Tumor-Infiltrating Lymphocyte (TIL) therapy – two groundbreaking treatments that help boost the body’s own immune system to fight against cancer.
The partnership, set to run for two years with the possibility of further extension, was signed by Dr. Thomas Launey, Chief Researcher of TII’s Biotechnology Research Center, and Dr. Khaled Musallam, Chief Research Officer of Burjeel Holdings, in the presence of Dr. Ray O. Johnson, CEO, TII, and Safeer Ahamed, Group COO, Burjeel Holdings, at the Abu Dhabi Global Healthcare Week. BMC, known for its complex care offerings in key specialties including oncology, will leverage cutting-edge technologies from TII, such as its state-of-the-art computational framework to identify patient-specific antigens relevant to cancer, and develop personalized cancer therapies. In Phase 1 of the project, TII will construct an in-silico platform to identify tailored cancer-specific antigens from single-cell transcriptomics data. This platform will facilitate the design of CAR-T cells capable of effectively targeting cancer-specific antigens. During Phase 2, the in-silico platform will undergo rigorous testing through in-vitro and in-vivo experiments.
Dr. Thomas Launey, said: “We expect that this collaboration with BMC will yield fast and meaningful impact in cancer therapy. Together, we are committed to pushing the boundaries of innovation to provide hope to those affected by this critical health challenge.”
Dr. Khaled Musallam, said, “We live in times where cancers continue to proliferate with a ruthless and growing frequency, impacting the lives of those affected and their families. This is clearly not a struggle the healthcare sector can overcome alone. Creating partnerships that help supercharge cancer research and treatment are crucial to enhance the pace of discoveries and improve patient outcomes. Our partnership with TII will play a pivotal role in the ongoing fight against cancer.”
With the UAE fast becoming a key leader in innovative cancer care through various strategic initiatives, the TII-Burjeel alliance is a clear indication of the country’s commitment to collaborative progress in oncology, fostering breakthrough solutions that will elevate the healthcare industry to new heights.
# # #
About Technology Innovation Institute (TII)
The Technology Innovation Institute (TII) is the dedicated applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC). TII is a pioneering global research and development center that focuses on applied research and new-age technology capabilities. The Institute has 10 dedicated research centers in advanced materials, autonomous robotics, cryptography, AI and digital science, directed energy, quantum, secure systems, propulsion and space, biotechnology, and renewable and sustainable energy. By working with exceptional talent, universities, research institutions, and industry partners from all over the world, TII connects an intellectual community and contributes to building an R&D ecosystem that reinforces the status of Abu Dhabi and the UAE as a global hub for innovation.
For more information, visit https://www.tii.ae/
Connect with us on social media:
LinkedIn: https://www.linkedin.com/company/tiiuae/
Twitter: https://twitter.com/TIIuae
Instagram: https://www.instagram.com/tiiuae/
For media inquiries, please contact:
Technology Innovation Institute
About Burjeel Medical City
Burjeel Medical City (BMC) is a 400-bed multispecialty hospital and quaternary care center located in Abu Dhabi, UAE. It is the region’s complex care hub with over 60 adult and pediatric specialties, aided by state-of-the-art medical technology and an international team of experts. The 1.2 million-square-foot hospital is a flagship facility under the Burjeel Holdings umbrella. It is renowned for key specialties including oncology, hematology, bone marrow transplantation, neurosurgery, multi-organ transplantation, advanced orthopedic surgery, pediatric subspecialties, fetal medicine, nuclear medicine, and advanced gynecology. The hospital is the first to receive ESMO accreditation as an Integrated Oncology and Palliative Care Center. BMC is the Reference Site for Elekta and Novalis Certified Radiosurgery Centers. Visit: https://burjeelmedicalcity-stage.burjeelholdings.com/
Connect with us on social media:
LinkedIn: https://www.linkedin.com/company/burjeel-medical-city/
Twitter: https://x.com/burjeelmedicity
Instagram: https://instagram.com/burjeelmedicity
Facebook: https://www.facebook.com/BurjeelMediCity
For media inquiries, please contact:
M Unnikrishnan, Corporate Communications Officer, Burjeel Holdings
krish@burjeelholdings.com
Burjeel Holdings Excels at Nafis Award, Secures Three First Places for Emirati Talent Development
Dr. Shamsheer Vayalil received the award presented to Burjeel in the large-sized entities category, while two Emirati employees received awards in the individuals category and three received recognitions
Abu Dhabi: In a significant stride towards nurturing Emirati talent within the healthcare sector, Burjeel Holdings has clinched three prestigious awards during the second cycle of the Nafis Award. The accolades reflect the healthcare Group’s concerted efforts to bolster the participation of Emirati nationals in the healthcare workforce.
The Nafis Award, an initiative launched as part of the ‘Projects of the 50’ agenda, aims to enhance the competitiveness of Emirati human resources and empower them to occupy jobs in the private sector. The Award was launched under the patronage and guidance of His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister, Minister of the Presidential Court, Chairman of the Emirati Talent Competitiveness Council.
During a ceremony held in Abu Dhabi, the Emirati Talent Competitiveness Council announced the names of the national winners in the individual category during the second cycle of the Nafis Award. Thirty citizens employed in the private and banking sectors secured the top three positions across ten fields of work.
Clinching Three Awards
Burjeel Holdings has distinguished itself by securing three awards, underscoring the Group’s unwavering dedication to empowering Emiratis and creating avenues for their career advancement within the healthcare industry. Burjeel won the award in the large-sized entities category, and it was received by Dr. Shamsheer Vayalil, the Group’s Founder and Chairman, during the ceremony. In the individuals category, Prof. Humaid Al Shamsi, Director of Oncology Services, Burjeel Holdings, and Dr. Mariam Al Suwaidi, Consultant Dermatology, Burjeel Day Surgery Center, Al Reem Island, secured first place.
Aysha Al Mahri, Deputy CEO of Burjeel Medical City; Naser Al Riyami, Chief Operating Officer of Projects at Burjeel Holdings; and Sara Al Katheeri, Nutritionist at Burjeel Medical City, also received recognition.
Speaking on the achievement, Dr. Shamsheer Vayalil remarked, “We are honored to receive these prestigious awards, which underscore our commitment to nurturing local expertise and empowering Emiratis in the private sector. We’ve witnessed a remarkable surge in Emirati professionals across diverse departments and hierarchical levels within Burjeel Holdings, with hundreds of UAE nationals contributing to our workforce. This uptick underscores our dedication to cultivating local talent and facilitating avenues for career advancement within the healthcare sector.”
Empowering Emiratis in Healthcare
The Nafis program has been instrumental in facilitating Burjeel Holdings’ endeavors to amplify Emirati involvement in healthcare careers. The success at the Nafis Award highlights Burjeel Holdings’ dedication to excellence in Emirati healthcare participation. Through a series of workshops and training initiatives conducted in collaboration with the Nafis program, the Group has actively nurtured a culture of continuous learning and growth among Emirati healthcare professionals. Furthermore, Burjeel Holdings has bolstered its commitment to nurturing local talent through comprehensive training initiatives in collaboration with esteemed academic institutions like Fatima College of Health Sciences, Higher College of Technology, and United Arab Emirates University. The Group has offered structured programs encompassing internships and developmental schemes for students to gain hands-on experience. Additionally, from December 2023 to April 2024, the Group sponsored 70 students across all Burjeel units by collaborating with the Ministry of Human Resources and Emiratisation.
“We are proud to receive this prestigious award, which is a reflection of the dedication and hard work of our team at Burjeel Holdings. We extend our gratitude to the visionary leadership of the UAE, whose unwavering support and guidance continue to inspire us. As Emiratis, our goal is to wholeheartedly contribute to realizing the ambitious vision set forth by our leaders, and this recognition reaffirms our commitment to advancing the nation’s prosperity and excellence,” said Prof. Humaid Al Shamsi.
Burjeel Holdings currently employs a total of 485 UAE nationals, comprising doctors, nurses, allied healthcare professionals, and administrative staff.
(ENDS)
Department of Health – Abu Dhabi honors Burjeel Medical City for exceeding Emiratization targets
Abu Dhabi: Following the announcement that the Emirate’s healthcare sector had attracted more than 1,200 healthcare professionals within six months of introducing the Tawteen targets, the Department of Health – Abu Dhabi (DoH), has honored the seven top-performing healthcare facilities, including BMC — Burjeel Medical City, that exceeded the Emiratization targets, Tawteen, in 2023.
This comes in line with the department’s efforts to provide more job opportunities for UAE Nationals, enhancing their contributions to Abu Dhabi’s healthcare system, and achieving the Emiratization targets set by DoH, which includes employing 5,000 UAE citizens by the end of 2025.
The award ceremony was held at the department’s headquarters in the presence of His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the DoH, Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, and His Excellency Ghannam Al Mazrouei, Secretary General of the Emirati Talent Competitiveness Council, in addition to high-level representatives from distinguished healthcare facilities.
The event recognized national talents who recently joined the healthcare sector, as well as the seven top-performing facilities in Abu Dhabi, Al Ain, and Al Dhafra. Omran Al Khoori, Member of the Board of Directors at Burjeel Holdings, along with Safeer Ahamed, Group COO of Burjeel Holdings, and Tahani Abdo Ahmed Al Qadiri, Director of Emiratization and Academics, received the award during the ceremony.
Her Excellency Dr Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said: “Today, we celebrate the top-performing healthcare facilities that have not only achieved but exceeded their Tawteen targets, setting an example for others and providing the sector with a competent and skilled healthcare workforce. Following the directives of our wise leadership, the Tawteen initiative has played a key role in job creation, facilitating employment opportunities for national job seekers, reaching a growth rate of 12 per cent in the national workforce by the end of 2023 exceeding the annual target of this initiative.”
His Excellency Ghannam Al Mazrouei, Secretary General of the Emirati Talent Competitiveness Council (ETCC), said: “The ongoing collaboration between Emirati Talent Competitiveness Council and the Department of Health – Abu Dhabi (DoH) has facilitated the attraction and retention of a significant number of national graduates and job seekers in the workforce. This underscores our collective efforts to attract local talents and implement Emiratization strategies in line with the directives of the UAE’s wise leadership, which prioritizes empowering the nation
Global Oncology Leaders Converge as Abu Dhabi Hosts its First WIN Symposium
- Nobel Laureate Prof. James Allison, whose work has revolutionized cancer immunotherapy, delivered the keynote lecture
- The global congress of the WIN Consortium brings together top physicians, researchers and scientists in precision oncology from across the world
- Held in partnership with Burjeel Holdings, the congress is being conducted outside Europe for the first time
ABU DHABI: The WIN Symposium 2024, a landmark event in precision oncology, has officially commenced in Abu Dhabi, marking a significant collaboration between the Worldwide Innovative Network (WIN) Consortium and Burjeel Holdings. This two-day annual global congress of the WIN Consortium brings together over 500 physicians, researchers, and scientists in the field from 30 countries to explore the latest advancements in precision oncology, with the ultimate goal of improving cancer patient care and outcomes worldwide.
Nobel Laureate Presents Latest Research on Immunotherapy
Under the theme ‘Precision and Molecular Oncology: Caring for Patients and Future Generations,’ the congress kicked off with a grand opening featuring 2018 Nobel Laureate, Prof. James Allison, Regental Professor and Chair of the Department of Immunology at the MD Anderson Cancer Center (USA), whose groundbreaking work has revolutionized cancer immunotherapy. In his keynote lecture, Prof. Allison, presented the latest research on how immunotherapy works and the way in which treatments can be improved, tailored and combined so that they are more effective and safe to give to patients with various types of cancer.
On the sidelines of the event, Prof. Allison, said, “We are excited to be here and hear about what is happening in the UAE. We are impressed by the infrastructure being built for the development of patient care and cancer treatment, particularly in precision oncology, genomic medicine, and immunotherapy. The future is already here in terms of collaboration with various groups, including those planning infrastructure and building medical systems in Abu Dhabi, especially in clinical trials and the testing of new drugs.”
The WIN Consortium, a non-profit association headquartered in France, unites 31 world-class academic medical centers, healthcare industries, research organizations, and patient advocacy groups from 18 countries, aligned to launch cancer trials using omic platforms to bolster precision oncology across the world. BMC — Burjeel Medical City, the flagship facility of Burjeel Holdings, is the first and only member from the UAE and GCC. Abu Dhabi was selected as the city to host this year’s congress, marking its inaugural occurrence outside of its traditional European venue.
This decision reflects the international scientific community’s trust in the UAE’s vision and capabilities in advancing precision oncology.
During the opening ceremony, Dr. Asma Al Mannaei, Executive Director, Research and Innovation Center at Department of Health – Abu Dhabi, outlined the DoH’s plans for precision medicine. “The Department of Health is at the forefront of integrating advanced tools and strategies at both clinical and genomic data levels. Our goal is to not just promote precision research and care but to revolutionize it, ensuring that personalized healthcare is not a luxury, but a standard,” said Dr. Asma.
Transforming Cancer Care
Emphasizing the importance of collaborative efforts in transforming cancer care, Prof. Wafik El-Deiry, Chair, WIN Consortium, Director, Legorreta Cancer Center, Brown University (USA) said, “Treating patients with cancer without fully understanding established and emerging molecular biomarkers for cancer outcomes can severely limit many aspects of patient care. The global WIN Consortium in cancer personalized medicine is pleased to collaborate with a strong scientific partner such as Burjeel Holdings to bring the premiere annual precision oncology WIN Symposium to Abu Dhabi. The world-class clinical and research faculty including Nobel Laureate James Alison are discussing how biomarkers, technologies and intelligent algorithms are helping patients with advanced cancer access the best life-prolonging treatment combinations and approaches that are transforming cancer care in the field of precision oncology.”
The congress features a meticulously curated program, featuring interactive elements that illustrate the principles and best practices of precision cancer treatment. Key opinion leaders and innovators from prestigious institutions worldwide and major precision diagnostic companies are participating, fostering discussions on the latest advancements in precision medicine.
Dr. Shamsheer Vayalil, Founder and Chairman, Burjeel Holdings, highlighted the Group’s commitment to cancer care, stating, “We are committed to advancing our understanding of cancer and work towards improving patient care, not only for the current but also for future generations in the UAE and region. The only way for us to do this is through fostering an engaging dialogue between international scholars and innovators and local experts to bridge theory and real-world practice and forge lasting partnerships.”
Comprehensive Sessions
Emphasizing the necessity of individualized patient treatment in the era of precision medicine, Prof. Humaid Al Shamsi, Director of Oncology Services, Burjeel Holdings, said, “We are living in an era when patient treatment must be individualized. The same type of cancer can develop and behave differently in different individuals due to the specific underlying genetic and cellular changes. Today, we are blessed with having several options to target these specific changes but selecting the right therapeutic agent can be complex. We have thus developed a program over two days to tackle every aspect of the journey towards selecting the right drug for the right patient. This will inevitably uplift our standards of practice in the country and reflect on patient outcomes.”
Dr. Khaled Musallam, Group Chief Research Officer, Burjeel Holdings who highlighted the meeting’s goal to connect research with clinical practice, said “Our goal in this meeting was to offer a platform that connects the ‘bench’ with the ‘bedside’ and provide a roadmap for best-practice to the treating clinicians. The longstanding experience of the WIN Consortium as a global reference for research and education on precision oncology and the vision of Burjeel Holdings to bring the standards of cancer care and research to international levels were key ingredients to the recipe for success of this meeting.”
“Make A Wish” in collaboration with the “Ministry of Interior” and “Burjeel” grant wishes for children on International Childhood Cancer Day
